Site Map

Valley fever

San Joaquin Valley fever; Coccidioidomycosis; Cocci; Desert rheumatism

Valley fever is an infection that occurs when the spores of the fungus Coccidioides immitis enter your body through the lungs.

Images

Coccidioidomycosis - chest X-ray
Pulmonary nodule - front view chest x-ray
Disseminated coccidioidomycosis
Fungus

Causes

Valley fever is a fungal infection most commonly seen in the desert regions of the southwestern United States, and in Central and South America. You get it by breathing in the fungus from soil. The infection starts in the lungs. It commonly affects people over 60 years of age.

Valley fever may also be called coccidioidomycosis.

Traveling to an area where the fungus is commonly seen raises your risk for this infection. However, you're more likely to develop a serious infection if you live where the fungus is found and have a weakened immune system due to:

People of Native American, African, or Philippine descent are disproportionately affected.

Symptoms

Most people with valley fever never have symptoms. Others may have cold- or flu-like symptoms or symptoms of pneumonia. If symptoms occur, they typically start 5 to 21 days after exposure to the fungus.

Common symptoms include:

Rarely, the infection spreads from the lungs through the bloodstream to involve the skin, bones, joints, lymph nodes, and central nervous system or other organs. This spread is called disseminated coccidioidomycosis.

People with this more widespread form may become very sick. Symptoms may also include:

Skin lesions of valley fever are often a sign of widespread (disseminated) disease. With more widespread infection, skin sores or lesions are most often seen on the face.

Exams and Tests

The health care provider will perform a physical exam and ask about symptoms and travel history. Tests done for milder forms of this infection include:

Tests done for more severe or widespread forms of the infection include:

Treatment

If you have a healthy immune system, the disease almost always goes away without treatment. Your provider may suggest bed rest and treatment for flu-like symptoms until your fever disappears.

If you have a weak immune system, you may need antifungal treatment with amphotericin B, fluconazole, or itraconazole. Itraconazole is the drug of choice in people with joint or muscle pain.

Sometimes surgery is needed to remove the infected part of the lung (for chronic or severe disease).

Outlook (Prognosis)

How well you do depends on the form of the disease you have and your overall health.

The outcome in acute disease is likely to be good. With treatment, the outcome is usually also good for chronic or severe disease (although relapses may occur). People with disease that has spread have a high death rate.

Possible Complications

Widespread valley fever may cause:

These problems are much more likely if you have a weakened immune system.

When to Contact a Medical Professional

Contact your provider for an appointment if you have symptoms of valley fever or if your condition does not improve with treatment.

Prevention

People with immune problems (such as with HIV/AIDS and those who are on drugs that suppress the immune system) shouldn't go to areas where this fungus is found. If you already live in these areas, other measures that can be taken include:

Take preventive medicines as prescribed by your provider.

Related Information

Spores
HIV/AIDS
Abscess
Empyema
Meningitis
Immunodeficiency disorders
Pleural effusion

References

Centers for Disease Control and Prevention website. Valley fever (coccidioidomycosis). www.cdc.gov/fungal/diseases/coccidioidomycosis/index.html. Updated December 29, 2020. Accessed November 11, 2022.

Elewski BE, Hughey LC, Hunt KM, Hay RJ. Fungal diseases. In: Bolognia JL, Schaffer JV, Cerroni L, eds. Dermatology. 4th ed. Philadelphia, PA: Elsevier; 2018:chap 77.

Galgiani JN. Coccidioidomycosis (Coccidioides species). In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 9th ed. Philadelphia, PA: Elsevier; 2020:chap 265.

BACK TO TOP

Review Date: 9/10/2022  

Reviewed By: Jatin M. Vyas, MD, PhD, Associate Professor in Medicine, Harvard Medical School; Associate in Medicine, Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, MA. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

ADAM Quality Logo
Health Content Provider
06/01/2025

A.D.A.M., Inc. is accredited by URAC, for Health Content Provider (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics. This site complied with the HONcode standard for trustworthy health information from 1995 to 2022, after which HON (Health On the Net, a not-for-profit organization that promoted transparent and reliable health information online) was discontinued.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2024 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

A.D.A.M. content is best viewed in IE9 or above, Firefox and Google Chrome browser.